SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma - Trautmann, Marcel; Sievers, E.; Aretz, S.; Kindler, D.; Michels, S.; Friedrichs, N.; Renner, Marcus; Kirfel, J.; Steiner, S.; Huss, S.; Koch, A.; Penzel, Roland; et al. (Oncogene, 2014)
published online 28 October 2013